MAY 24, 2016 3:32 AM PDT

Nanomedicine Delivers Chemotherapy Drugs to Brain Tumors

WRITTEN BY: Xuan Pham

By packing chemotherapy drugs in nanoscale lipid droplets, researchers say they may have found a new way to treat one of the deadliest forms of primary brain cancer known as glioblastoma multiforme (GBM). Nanotheraputics, as this field of medicine is now called, combines nanotechnology, chemistry, and bioengineering into a remarkable system with seemingly “endless and bright” possibilities, said Ann-Marie Broome, senior author of the newly published study.

 
Image credit: Pixabay.com
 

 Dubbed as the “octopus tumor,” GBMs are characterized with malignant glial cells forming vast networks of tendrils throughout the brain. This makes it nearly impossible to surgically remove all the cancerous tissues. As such, this brain cancer can evade even the most aggressive surgeries, chemotherapies, and radiotherapies, leaving patients with a five-year survival rate of less than 10 percent.
 
Another part of the reason why chemotherapy is ineffective against GBM is the blood-brain barrier (BBB). Designed to protect the brain from the environment, the BBB also prevents drugs from passing through to act on the GBM cancer cells.
 
To breach the BBB, Broome and her team aimed at creating nanocarriers that could ferry drugs into the brain. They designed a micelle – “a bit of fat globule” – that was so small it easily slipped past the BBB. Inside the micelle, the team packaged the chemotherapy drug, temozolomide (TMZ).
 
"Micelles of a certain size will cross the blood-brain barrier carrying a concentrated amount of TMZ," Broome said. To the micelles, they also incorporated platelet-derived growth factors (PDGF), which are proteins that are overexpressed in the cancer cells. "The PDGF is used much like a postal address. The micelle gets it to the street, and the PDGF gets it to the house."
 
Once inside the cancer, the team exploited cancer’s unnatural acidic environment to trigger the release of the drug. "We take advantage of the tumor's natural environment as well as the cellular expression. I'm a big proponent of understanding that microenvironment has an impact on how well you can treat tumors. It's probably why so many therapeutics fail - because you have to take into account the immune system, the local environment, and the cells themselves - all three of these are important considerations."
 
In experiment results, this method worked so well that Broome initially questioned her results. "I was very surprised by how efficiently and well it worked once we got the nanocarrier to those cells," said Broome. But after many validation experiments in different cell lines and using different drug concentrations, the results still proved promising.
 
In the next phase, Broome anticipates more testing with different drugs and other biomarkers for GBM. "[TMZ] may or may not be effective for all types of GBMs. There are subtypes as well as therapeutic-resistant GBMs that these nanocarriers may not impact. We need to continue rigorous testing to verify and validate our initial findings."
 
But for now, the team is excited for the possibilities that have opened up with this nanotherapeutics technology. 
 


Additional source: Medical University Of South Carolina news release

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 05, 2020
Cancer
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
AUG 05, 2020
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
Cell-free DNA (cfDNA) are small pieces of genomic DNA that have escaped into the bloodstream either through active relea ...
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
AUG 17, 2020
Microbiology
Ingestible Bacteria-Catcher Could Act as a Diagnostic Tool
AUG 17, 2020
Ingestible Bacteria-Catcher Could Act as a Diagnostic Tool
Microbes in our gastrointestinal tract may not only be closely linked to our health, but they may also be useful as a di ...
AUG 27, 2020
Clinical & Molecular DX
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
AUG 27, 2020
Genetic Tool Predicts Breast Cancer Risk in Women of Asian Ancestry
  Many diseases such as breast cancer have both a strong genetic component, coupled with a variety of environmental ...
OCT 01, 2020
Cardiology
Investigating Inflammation in Coronary Artery Bypass Grafts
OCT 01, 2020
Investigating Inflammation in Coronary Artery Bypass Grafts
The heart is a vital part of the body that can last one hundred years, yet even a small change can cause massive consequ ...
OCT 03, 2020
Clinical & Molecular DX
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
OCT 03, 2020
Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age
Researchers at Harvard have discovered a novel diagnostic marker of dementia for identifying undiagnosed patients or tho ...
Loading Comments...